Amarin Corp Plc (AMRN)

[Jt0082]

don't think you could ask for a more positive call and opinion from this doc. I am taking him at his word.

basically stated adoption would be nothing short of massive if hits.

and also that they enrolled the right patients and that the dosage of 4g of pure EPA is the key differentiator.

Only disconfirming evidence is the share price with significant volume which I am putting down to simply nervous pre-trial binary action, people who traded this for the run-up exiting, stop losses, consonance selling down, limited understanding that its not fish oil and that reduce-it is not related to ASCEND or VITAL.

I just increased my position by 50%.

crossing fingers this doc is right.

PS. Kiwi keeps on banging on about this trial not being designed well because LDL levels are already low. I think he is missing the point totally. LDL needs to be low and controlled in the trial in order to assess the benefit of EPA alone, its lowering of trigs independently of LDL and the associated read through to outcomes data.